APAC IPOs & Placements

Zhen Zhou, Toh

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Genscript Biotech / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/21041" target="_blank" data-smartkarma-citation="entities:21041:1">Genscript Biotech Corp (1548 HK)</a> is looking to raise US$304m by selling 90m shares (including 15m top-up primary shares). This is a concurrent top-up of primary shares and secondary selldown by Wang Ye who is an executive director, the president and one of the controlling shareholders of the company.</p><p>The deal scores well on our framework owing to the strong earnings and price momentum but was partially offset by its expensive valuation. The company is raising money to mainly build up CAR-T R&amp;D…</p>

Genscript Biotech Corp (1548 HK) is looking to raise US$304m by selling 90m shares (including 15m top-up primary shares). This is a concurrent top-up of primary shares and secondary selldown by Wang Ye who is an executive director, the president and one of the controlling shareholders of the company.The deal scores well on our framework owing to the strong earnings and price momentum but was partially offset by its expensive valuation. The company is raising money to mainly build up CAR-T R&amp;D…

Genscript Biotech Placement - Raising Money to Build Up CAR-T R&D and Production Facilities